Feng Zhang

Feng Zhang is the James & Patricia Poitras Professor in Neuroscience at the Department of Brain & Cognitive Sciences, Massachusetts Institute of Technology (MIT). He leads a lab focusing on developing and applying cutting-edge genetic and genomic tools, particularly CRISPR-based technologies, for biomedical research and clinical applications. His work spans genome editing, optogenetics, and molecular diagnostics, with significant contributions to SARS-CoV-2 testing and antiviral strategies.

Research interests include CRISPR-Cas systems engineering, RNA editing, viral pathogenesis, and neurotechnologies for studying brain function. Zhang's lab has pioneered tools like SHERLOCK for rapid nucleic acid detection and developed optogenetic methods to study neural circuits. His work integrates synthetic biology, molecular genetics, and computational approaches to address fundamental biological questions and translational challenges in medicine.

Notable contributions include CRISPR-Cas9 and Cas13 applications in genome editing, antiviral strategies, and diagnostic platforms. His innovations have advanced therapies for genetic disorders, cancer, and infectious diseases. The lab collaborates widely across academic and industry partners to translate discoveries into clinical tools.

Scientific awards and recognitions are omitted here as none were explicitly listed in the provided texts. Zhang's research has been featured in high-impact journals and patents, reflecting his leadership in genomic technologies.